Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Mechanism of herbicide analogue XK-469's antitumor activity pinpointed

Oct. 20, 1999

Onyx and Warner-Lambert collaborate on development of anticancer virus products

Oct. 20, 1999

DuPont granted patent rights to Duke's new antiestrogens

Oct. 19, 1999

Therion Biologics and NCI initiate phase II trial of novel melanoma vaccines

Oct. 19, 1999

Ariad discloses a wide series of cellular signal transduction inhibitors

Oct. 18, 1999

The Liposome Company to resubmit its NDA for Evacet

Oct. 15, 1999

Inhibitors of tumor cell proliferation patented by Roche

Oct. 15, 1999

NuChem's anticancer drug candidates to be featured at upcoming oncology meeting

Oct. 14, 1999

Disappointing results reported from phase III lisofylline trial

Oct. 14, 1999

Vion to commence phase I trial of VNP-20009

Oct. 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....